Nifty
Sensex
:
:
11873.05
40431.60
110.60 (0.94%)
448.62 (1.12%)

Pharmaceuticals & Drugs - API

Rating :
77/99

BSE: 532488 | NSE: DIVISLAB

3093.40
19-Oct-2020
  • Open
  • High
  • Low
  • Previous Close
  •  3235.00
  •  3246.90
  •  3085.00
  •  3222.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1329702
  •  41631.58
  •  3389.00
  •  1626.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 82,105.45
  • 51.44
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 82,016.45
  • 0.52%
  • 10.52

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.96%
  • 1.41%
  • 8.73%
  • FII
  • DII
  • Others
  • 18.28%
  • 18.52%
  • 1.10%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.15
  • 7.39
  • 11.50

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.79
  • 5.15
  • 7.62

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.36
  • 4.10
  • 16.21

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 29.35
  • 31.81
  • 36.92

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.54
  • 6.51
  • 6.74

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.17
  • 22.52
  • 25.37

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
1,730.47
1,162.88
48.81%
1,389.71
0.00
0
1,396.26
1,359.96
2.67%
1,445.57
1,323.93
9.19%
Expenses
1,030.39
775.74
32.83%
945.26
0.00
0
902.36
827.09
9.10%
955.01
802.44
19.01%
EBITDA
700.08
387.14
80.83%
444.45
0.00
0
493.90
532.87
-7.31%
490.56
521.49
-5.93%
EBIDTM
40.46%
33.29%
14.01%
0.00%
35.37%
39.18%
33.94%
39.39%
Other Income
17.33
30.32
-42.84%
76.73
0.00
0
41.67
34.43
21.03%
47.03
80.43
-41.53%
Interest
0.23
0.32
-28.12%
0.44
0.00
0
1.55
2.52
-38.49%
3.79
0.24
1,479.17%
Depreciation
56.20
43.83
28.22%
49.78
0.00
0
46.70
42.50
9.88%
45.93
42.41
8.30%
PBT
660.98
373.31
77.06%
470.96
0.00
0
487.32
522.28
-6.69%
487.87
559.27
-12.77%
Tax
168.92
100.87
67.46%
82.73
0.00
0
128.23
132.90
-3.51%
131.09
155.55
-15.72%
PAT
492.06
272.44
80.61%
388.23
0.00
0
359.09
389.38
-7.78%
356.78
403.72
-11.63%
PATM
28.43%
23.43%
7.11%
0.00%
25.72%
28.63%
24.68%
30.49%
EPS
18.53
10.26
80.60%
14.62
0.00
0
13.53
14.67
-7.77%
13.44
15.21
-11.64%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
-
5,394.42
4,946.26
3,891.49
4,064.34
3,776.36
3,114.94
2,532.14
2,144.84
1,863.87
1,316.54
Net Sales Growth
-
9.06%
27.10%
-4.25%
7.63%
21.23%
23.02%
18.06%
15.07%
41.57%
 
Cost Of Goods Sold
-
2,108.54
1,825.22
1,534.06
1,534.00
1,505.32
1,213.24
914.15
798.63
761.64
512.82
Gross Profit
-
3,285.88
3,121.04
2,357.43
2,530.34
2,271.04
1,901.70
1,617.99
1,346.21
1,102.23
803.72
GP Margin
-
60.91%
63.10%
60.58%
62.26%
60.14%
61.05%
63.90%
62.77%
59.14%
61.05%
Total Expenditure
-
3,571.21
3,073.24
2,628.74
2,617.20
2,358.04
1,948.69
1,516.76
1,328.87
1,172.59
815.64
Power & Fuel Cost
-
280.73
248.66
228.73
198.80
180.34
170.82
147.40
131.02
86.13
62.65
% Of Sales
-
5.20%
5.03%
5.88%
4.89%
4.78%
5.48%
5.82%
6.11%
4.62%
4.76%
Employee Cost
-
621.05
542.27
456.06
499.90
361.19
290.42
232.46
197.72
150.85
117.23
% Of Sales
-
11.51%
10.96%
11.72%
12.30%
9.56%
9.32%
9.18%
9.22%
8.09%
8.90%
Manufacturing Exp.
-
258.91
212.96
182.67
169.15
169.42
147.24
121.10
104.85
86.61
65.13
% Of Sales
-
4.80%
4.31%
4.69%
4.16%
4.49%
4.73%
4.78%
4.89%
4.65%
4.95%
General & Admin Exp.
-
148.62
105.42
139.33
88.22
73.91
63.85
51.74
44.15
32.47
27.57
% Of Sales
-
2.76%
2.13%
3.58%
2.17%
1.96%
2.05%
2.04%
2.06%
1.74%
2.09%
Selling & Distn. Exp.
-
85.36
73.08
64.02
67.48
56.04
51.93
44.22
51.29
53.63
29.80
% Of Sales
-
1.58%
1.48%
1.65%
1.66%
1.48%
1.67%
1.75%
2.39%
2.88%
2.26%
Miscellaneous Exp.
-
68.00
65.63
23.87
59.65
11.80
11.18
5.69
1.21
1.27
29.80
% Of Sales
-
1.26%
1.33%
0.61%
1.47%
0.31%
0.36%
0.22%
0.06%
0.07%
0.03%
EBITDA
-
1,823.21
1,873.02
1,262.75
1,447.14
1,418.32
1,166.25
1,015.38
815.97
691.28
500.90
EBITDA Margin
-
33.80%
37.87%
32.45%
35.61%
37.56%
37.44%
40.10%
38.04%
37.09%
38.05%
Other Income
-
189.63
155.63
113.44
74.89
97.44
44.70
70.60
44.81
56.05
27.12
Interest
-
7.14
4.68
2.37
3.36
4.74
2.88
2.96
2.59
4.61
2.26
Depreciation
-
186.24
168.90
142.49
123.33
118.18
136.00
92.12
76.95
62.08
53.40
PBT
-
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
680.63
472.37
Tax
-
442.92
502.33
354.32
334.92
267.06
220.56
217.58
179.23
147.36
43.10
Tax Rate
-
24.34%
27.08%
28.78%
24.00%
19.17%
20.57%
21.96%
22.94%
21.65%
9.12%
PAT
-
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
533.26
429.27
PAT before Minority Interest
-
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
533.26
429.27
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
25.52%
27.35%
22.54%
26.09%
29.81%
27.34%
30.54%
28.07%
28.61%
32.61%
PAT Growth
-
1.76%
54.24%
-17.30%
-5.81%
32.21%
10.11%
28.46%
12.89%
24.22%
 
EPS
-
51.85
50.95
33.03
39.94
42.40
32.07
29.13
22.67
20.09
16.17

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
7,309.92
6,957.15
5,924.80
5,357.39
4,293.31
3,495.36
2,963.35
2,500.60
2,131.52
1,797.48
Share Capital
53.09
53.09
53.09
53.09
53.09
26.55
26.55
26.55
26.55
26.52
Total Reserves
7,256.83
6,904.06
5,871.71
5,304.30
4,240.21
3,468.81
2,936.80
2,474.05
2,104.98
1,769.98
Non-Current Liabilities
294.57
991.38
1,768.91
1,411.75
85.17
841.57
650.05
469.75
71.35
67.39
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.18
Unsecured Loans
0.00
0.00
0.00
0.00
0.47
1.05
1.55
2.10
2.56
2.74
Long Term Provisions
20.52
772.54
1,577.26
1,288.92
11.57
714.30
533.49
388.43
1.65
2.82
Current Liabilities
1,820.53
846.75
653.42
659.45
519.50
775.53
627.41
554.45
553.78
409.90
Trade Payables
590.72
492.26
411.21
445.80
232.69
226.87
151.70
160.44
159.54
123.00
Other Current Liabilities
290.09
243.59
175.46
176.63
240.58
203.45
147.80
130.08
135.83
105.35
Short Term Borrowings
33.63
105.60
63.11
35.74
41.42
25.07
16.32
30.51
50.20
13.62
Short Term Provisions
906.09
5.30
3.64
1.28
4.81
320.14
311.58
233.42
208.21
167.92
Total Liabilities
9,425.02
8,795.28
8,347.13
7,428.59
4,897.98
5,112.46
4,240.81
3,524.80
2,756.65
2,274.77
Net Block
2,781.85
2,087.77
1,996.19
1,559.19
1,438.77
1,308.89
1,221.84
908.72
738.42
589.93
Gross Block
3,514.26
2,633.93
2,373.45
1,793.95
2,196.08
1,953.02
1,740.34
1,338.35
1,092.05
885.70
Accumulated Depreciation
732.41
546.16
377.26
234.76
757.32
644.13
518.50
429.63
353.64
295.77
Non Current Assets
3,851.49
4,145.23
3,812.01
3,418.08
1,870.93
2,340.06
1,984.45
1,660.69
1,005.71
734.07
Capital Work in Progress
919.69
491.91
119.76
443.57
263.91
218.18
144.48
303.41
181.58
103.72
Non Current Investment
0.01
547.26
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
144.50
1,012.93
1,688.23
1,406.48
162.44
812.63
618.03
448.49
83.68
38.20
Other Non Current Assets
5.44
5.36
7.82
8.83
5.80
0.35
0.09
0.07
1.63
1.60
Current Assets
5,573.53
4,650.05
4,535.12
4,010.51
3,027.04
2,772.40
2,256.35
1,864.11
1,750.95
1,540.71
Current Investments
971.35
1,398.34
1,889.28
1,630.72
802.85
733.00
501.88
407.81
477.04
525.64
Inventories
1,863.86
1,772.34
1,350.67
1,319.91
1,207.83
1,162.64
932.42
835.69
678.96
571.71
Sundry Debtors
1,413.35
1,163.37
1,014.36
900.92
880.92
741.64
723.70
512.00
495.08
365.23
Cash & Bank
122.63
115.26
112.46
78.70
73.43
65.22
40.51
40.89
30.94
17.67
Other Current Assets
1,202.34
142.20
124.98
20.67
62.01
69.89
57.85
67.71
68.93
60.46
Short Term Loans & Adv.
999.77
58.54
43.37
59.59
42.88
54.98
48.16
57.97
63.25
57.36
Net Current Assets
3,753.00
3,803.30
3,881.70
3,351.06
2,507.54
1,996.87
1,628.95
1,309.66
1,197.16
1,130.81
Total Assets
9,425.02
8,795.28
8,347.13
7,428.59
4,897.97
5,112.46
4,240.80
3,524.80
2,756.66
2,274.78

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
1,215.94
954.30
775.86
1,150.37
1,037.86
826.33
556.75
479.97
338.36
326.55
PBT
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
680.63
472.37
Adjustment
60.01
83.51
32.19
93.87
60.94
91.24
77.55
59.25
26.87
26.87
Changes in Working Capital
-218.30
-499.84
-219.11
-37.14
-155.03
-125.55
-298.39
-186.05
-242.47
-139.28
Cash after chg. in Working capital
1,661.17
1,438.74
1,044.41
1,452.07
1,298.75
1,037.76
770.07
654.44
465.03
359.97
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-445.23
-484.44
-268.55
-301.70
-260.89
-211.43
-213.32
-174.47
-126.68
-33.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-83.47
-685.40
-478.30
-1,139.60
-406.41
-520.84
-305.15
-254.54
-204.41
-221.31
Net Fixed Assets
-1,302.55
-632.52
-255.54
222.19
-288.75
-286.31
-242.98
-368.08
-284.15
-132.66
Net Investments
974.24
-56.30
-257.57
-826.05
-77.22
-231.12
-94.07
69.23
48.60
-86.61
Others
244.84
3.42
34.81
-535.74
-40.44
-3.41
31.90
44.31
31.14
-2.04
Cash from Financing Activity
-1,091.42
-245.94
-314.16
2.38
-631.12
-302.95
-248.50
-230.76
-131.11
-104.16
Net Cash Inflow / Outflow
41.05
22.96
-16.60
13.15
0.33
2.54
3.10
-5.33
2.84
1.09
Opening Cash & Equivalents
2.10
-20.86
-4.26
-17.41
17.62
15.09
11.99
17.32
14.48
13.39
Closing Cash & Equivalent
43.15
2.10
-20.86
-4.26
17.95
17.62
15.09
11.99
17.32
14.48

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
275.38
262.09
223.20
201.82
161.73
131.67
111.63
94.20
80.29
67.74
ROA
15.11%
15.78%
11.12%
17.21%
22.49%
18.21%
19.92%
19.17%
21.20%
20.77%
ROE
19.30%
21.00%
15.55%
21.98%
28.91%
26.37%
28.31%
25.99%
27.15%
25.94%
ROCE
25.36%
28.50%
21.68%
28.75%
35.57%
33.06%
36.04%
33.21%
34.20%
28.16%
Fixed Asset Turnover
1.75
1.98
1.88
2.06
1.83
1.70
1.66
1.78
1.90
1.55
Receivable days
87.17
80.35
89.33
79.19
77.83
85.12
88.42
85.08
83.45
80.71
Inventory Days
123.02
115.23
124.56
112.34
113.70
121.69
126.52
127.96
121.31
146.79
Payable days
54.82
52.21
60.15
47.14
35.06
33.55
36.16
42.47
42.66
63.49
Cash Conversion Cycle
155.38
143.37
153.75
144.39
156.47
173.26
178.78
170.58
162.09
164.00
Total Debt/Equity
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
Interest Cover
255.83
397.38
520.55
416.28
294.75
373.59
336.24
302.96
148.53
210.46

News Update:


  • Divi’s Laboratories reports 80% rise in Q1 consolidated net profit
    10th Aug 2020, 11:15 AM

    Total consolidated income of the company increased by 46.48% at Rs 1747.80 crore for Q1FY21

    Read More
  • Divis Lab - Quarterly Results
    8th Aug 2020, 12:37 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.